Inovio Investors Get Derivative Deal OK'd Over Vaccine Claims
By Emilie Ruscoe ( June 15, 2023, 9:12 PM EDT) -- Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over alleged misrepresentations about the company's efforts to produce a vaccine for COVID-19 in a matter of hours....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.